NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highlighting Obicetrapib's ... | Region
-- Presentations include new data from OCEAN, ROSE, and ROSE2 Phase 2 clinical trials, demonstrating obicetrapib’s impact on key lipid and lipoprotein biomarkers --
Source: eagletribune.com